Trade receivables increased 37.4%
Trade receivables changed +37.4% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$155.3M→$213.4M4 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →NEO financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Operating income increased 70.6%
Operating income changed +70.6% from the comparable as-filed period.
-$27.0M→-$7.9M2 prior comparisons
Cash & equivalents decreased 15.1%
Cash & equivalents changed -15.1% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
$164.1M→$139.3M4 prior comparisons
Current assets increased 7.2%
Current assets changed +7.2% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
$382.5M→$410.1M4 prior comparisons
Capital expenditure increased 41.6%
Capital expenditure changed +41.6% from the comparable as-filed period.
$8.3M→$11.8M2 prior comparisons
Operating cash flow changed across a sign change
Operating cash flow changed -200.0% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
$8.9M→-$8.9M2 prior comparisons
Gross profit increased 20.1%
Gross profit changed +20.1% from the comparable as-filed period.
$80.4M→$96.6M2 prior comparisons
Free-cash-flow proxy changed across a sign change
Free-cash-flow proxy changed -3724.2% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
$570,000→-$20.7M2 prior comparisons
Research & development increased 13.4%
Research & development changed +13.4% from the comparable as-filed period.
$8.7M→$9.9M2 prior comparisons
Stock-based compensation decreased 14.2%
Stock-based compensation changed -14.2% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$10.3M→$8.8M2 prior comparisons
Current liabilities increased 18.7%
Current liabilities changed +18.7% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
$97.9M→$116.2M4 prior comparisons
Working capital increased 3.3%
Working capital changed +3.3% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
$284.6M→$293.9M4 prior comparisons
Inventory decreased 10.4%
Inventory changed -10.4% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
$28.5M→$25.5M4 prior comparisons
Total assets increased 0.2%
Total assets changed +0.2% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
$1.4B→$1.4B4 prior comparisons
Shares outstanding increased 0.0%
Shares outstanding changed +0.0% from the comparable as-filed period. The change ranks at the 0th percentile of 8 prior comparable changes.
129,387,801→129,389,4658 prior comparisons
Current ratio decreased 9.7%
Current ratio changed -9.7% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
3.91→3.534 prior comparisons
Cost of revenue increased 5.0%
Cost of revenue changed +5.0% from the comparable as-filed period.
$107.4M→$112.7M2 prior comparisons
Working capital / assets moved 64 bp higher
Working capital / assets changed +64 basis points from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
20.70%→21.35%4 prior comparisons
Inventory decreased 20.6%
Inventory changed -20.6% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
$34.2M→$27.1M4 prior comparisons
Operating income increased 79.5%
Operating income changed +79.5% from the comparable as-filed period.
-$47.6M→-$9.8M2 prior comparisons
Free-cash-flow proxy decreased 16.2%
Free-cash-flow proxy changed -16.2% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$14.0M→$11.7M3 prior comparisons
Stock-based compensation decreased 32.7%
Stock-based compensation changed -32.7% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$12.2M→$8.2M2 prior comparisons
Capital expenditure increased 30.0%
Capital expenditure changed +30.0% from the comparable as-filed period.
$6.3M→$8.2M3 prior comparisons
Research & development increased 19.3%
Research & development changed +19.3% from the comparable as-filed period.
$9.0M→$10.8M2 prior comparisons
Shares outstanding decreased 0.5%
Shares outstanding changed -0.5% from the comparable as-filed period. The change ranks at the 12th percentile of 8 prior comparable changes. This reverses 8 consecutive comparable moves in the opposite direction.
129,178,622→128,475,4408 prior comparisons
Gross profit increased 18.9%
Gross profit changed +18.9% from the comparable as-filed period.
$77.3M→$91.9M2 prior comparisons
Trade receivables increased 14.6%
Trade receivables changed +14.6% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$153.1M→$175.4M4 prior comparisons
Operating cash flow decreased 1.8%
Operating cash flow changed -1.8% from the comparable as-filed period.
$20.3M→$20.0M3 prior comparisons
Cash & equivalents decreased 5.9%
Cash & equivalents changed -5.9% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$154.7M→$145.5M4 prior comparisons
Current ratio decreased 8.1%
Current ratio changed -8.1% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
3.92→3.64 prior comparisons
Working capital / assets moved 60 bp lower
Working capital / assets changed -60 basis points from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
20.98%→20.38%4 prior comparisons
Current liabilities increased 5.8%
Current liabilities changed +5.8% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
$100.1M→$105.9M4 prior comparisons
Working capital decreased 5.8%
Working capital changed -5.8% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$292.4M→$275.6M4 prior comparisons
Cost of revenue increased 5.5%
Cost of revenue changed +5.5% from the comparable as-filed period.
$104.1M→$109.8M2 prior comparisons
Total assets decreased 3.0%
Total assets changed -3.0% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$1.4B→$1.4B4 prior comparisons
Current assets decreased 2.8%
Current assets changed -2.8% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$392.6M→$381.5M4 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.